AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Israeli Billionaire Hires Black Cube to Spy on Former Partner Company Vale
2
The 50 most promising Israeli startups - 2024
3
Blackstone acquires Israel’s Priority Software at an $800 million valuation
4
Moritz code: Inside the mind of the best VC investor ever
5
Israel’s Tictuk acquired by Yum! Brands, owner of KFC, Pizza Hut, and Taco Bell
More news

Lawsuit

20 stories about Lawsuit
מטה חברת טבע תרופות

Teva Part of $50 Billion Opioid Settlement Deal, Report Says

17.10.19|Hezi Sternlicht
Teva, a second drugmaker, and the three largest drug distributors in the U.S. have agreed with multiple states on a settlement framework ahead of Monday’s trial, the New York Times reported Thursday
טל דיליאן לשעבר המפקד של היחידה הטכנולוגית של חיל המודיעין

The Cyber Company, the Former Officer, and the Lost Money

17.10.19|Meir Orbach
Three Israeli entrepreneurs are suing their former partners at cybersecurity startup Senpai Technologies, claiming they were cheated out of monetary compensation for their shares
אתר טבע כפר סבא

Teva Makes $15 Billion Settlement Offer in U.S. Opioid Case, Report Says

16.10.19|Hezi Sternlicht
The Israeli drugmaker and several other drug distributors are set to face around 2,500 lawsuits related to the U.S. opioid abuse epidemic in just a week at a Cleveland, Ohio federal court
מטה חברת טבע תרופות

Judge Rejects Teva’s Request to Be Tried Separately in U.S. Opioid Case, Report Says

13.10.19|CTech
Teva made a last minute attempt to be tried separately in opioid abuse damages case set to be held on October 21 in federal court in Cleveland, Ohio
מטה חברת טבע תרופות

Teva Crashes Following Purdue Pharma $10-$12 Billion Settlement Reports

28.08.19|Lilach Baumer
Teva, like many other opioid manufacturers operating in the U.S., will be facing multiple opioid abuse-related lawsuits at a trial set to start in October at an Ohio federal court
אתר טבע כפר סבא

Teva Faces New Opioid-Related Lawsuit in West Virginia

25.08.19|Hezi Sternlicht
The lawsuit seems to be unrelated to the trial set to start against Teva and other opioid manufacturers in October in Ohio federal court
מטה חברת טבע תרופות

Teva Jumps on NYSE on a Bit of Good News

21.08.19|Hezi Sternlicht
An opioid-abuse lawsuit settlement reached by drugmakers Endo and Allergan Tuesday could bode well for Teva’s legal future, as does the release of an FDA-approved generic version of EpiPen JR
מצלמה קורפוטוניקס

Smartphone Camera Developer Corephotonics Sues Apple, Again

15.08.19|Meir Orbach
Corephotonics filed a patent-infringement lawsuit against Apple to a Northern California district court Wednesday. The Israeli company first sued Apple in 2017
מימין נתי דוידי ו אורי אלטר מייסדי סייברה

Court Rules Tens of Millions of Dollars in Favor of Ousted Cyvera Co-Founder

11.08.19|Golan Hazani
Co-founder Moshe Ben Abu waived most of his stake in Cyvera prior to its acquisition by Palo Alto Networks for around $200 million in 2014
אתר טבע כפר סבא

Former Execs, Directors, to Pay Teva $50 Million for Part in Bribery Damages

25.07.19|Tomer Ganon
A recently reached settlement will see the Israeli drugmaker receive compensation for the fines it paid U.S. and Israeli authorities after being charged with conspiracy to violate the anti-bribery provisions of the Foreign Corrupt Practices Act in 2016
אתר טבע כפר סבא

Teva Falls on Pre-Market Trading After Morgan Stanley Downgrade

15.07.19|CTech
Teva recently reached an $85 million settlement with the State of Oklahoma regarding its alleged role in the state’s opioid crisis, but is still facing many more claims
דיוויד פרידמן טקס ב שגרירות ארה"ב ב ירושלים

Israeli Police Investigate Claim That Local Winery Scammed U.S. Ambassador

12.06.19|Tomer Ganon
In December, Calcalist reported that New York-based wine investment company Karraben Wine, previously owned by Ambassador David Friedman, sued an Israeli winery for fraud
אתר טבע כפר סבא

Fitch Downgrades Teva, Keeps Outlook at Negative

10.06.19|Hezi Sternlicht
Fitch pins the downgrade on the drugmaker's slow revenue growth, persisting cost challenges and downward pressure on generic drug prices, and the company's legal trouble in the U.S.
מטה חברת טבע תרופות

Derivative Suit Sheds Light on Teva’s Disastrous Rimsa Acquisition

28.05.19|Hezi Sternlicht
Teva acquired Mexican drugmaker Rimsa in 2016, but an anonymous email sent a week after the deal’s completion led Teva to launch an internal investigation—and sue the sellers for fraud
מטה חברת טבע תרופות

Teva Reaches $85 Million Settlement in Oklahoma Opioid Damages Suit

27.05.19|Hezi Sternlicht
Teva is one of several opioid manufacturers being sued in the U.S. by different states and private entities for its alleged role in the nation's opioid addiction crisis
מטה חברת טבע תרופות

This Is how Teva and 19 of its Rivals Fixed U.S. Drug Prices

15.05.19|Hezi Sternlicht, Ran Abramson, and Tomer Ganon
A 524-page civil lawsuit filed Friday in the U.S. alleges that 20 generic drugmakers colluded to influence drug prices, with executives meeting regularly to set prices and split the market
מטה חברת טבע תרופות

Teva’s Shady Legal Past Still Weighs on the Debt-Laden Pharma Company

12.05.19|Hezi Sternlicht
On Friday, 43 states joined Connecticut in filing a lawsuit against senior Teva executives and against over a dozen former and current senior executives at leading generic drug companies, alleging all were involved in a drug price-fixing conspiracy
מימין מנכ"ל אנבידיה ג'נסן הואנג ומנכ"ל מלאנוקס איל וולדמן

Investors Sue to Block Mellanox-Nvidia Deal, Report Says

02.05.19|CTech
Nvidia announced a deal to buy the Israeli chipmaker for $6.9 billion in March
גילה אדרעי רכבת ישראל

Train Workers Union Sues Israel Railways for Defamation

01.05.19|Lior Gutman
The lawsuit alleges that the railway’s management intentionally halted all trains for about two hours earlier this month, pinning the blame on the union to promote an initiative that would limit public service workers’ right to strike
מפעל טבע הר חוצבים ירושלים

Bidder Contests Teva Sale of Jerusalem Facility

31.03.19|Amitai Gazit and Lilach Baumer
Earlier this month, Teva agreed to sell the land tenure rights of its two Jerusalem factories, set to close by the end of 2019, for a combined $77 million
Previous ArticlesMore Articles